A detailed history of River Park Advisors, LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, River Park Advisors, LLC holds 3,697 shares of TMDX stock, worth $299,198. This represents 0.48% of its overall portfolio holdings.

Number of Shares
3,697
Previous 4,462 17.14%
Holding current value
$299,198
Previous $672,000 13.69%
% of portfolio
0.48%
Previous 0.56%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$135.68 - $176.11 $103,795 - $134,724
-765 Reduced 17.14%
3,697 $580,000
Q2 2024

Jul 26, 2024

SELL
$72.62 - $150.62 $117,644 - $244,004
-1,620 Reduced 26.64%
4,462 $672,000
Q1 2024

May 03, 2024

BUY
$70.86 - $89.93 $337,506 - $428,336
4,763 Added 361.11%
6,082 $449,000
Q4 2023

Jan 11, 2024

BUY
$36.74 - $81.08 $7,899 - $17,432
215 Added 19.47%
1,319 $104,000
Q3 2023

Nov 08, 2023

BUY
$53.47 - $96.07 $59,030 - $106,061
1,104 New
1,104 $60,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.58B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track River Park Advisors, LLC Portfolio

Follow River Park Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of River Park Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on River Park Advisors, LLC with notifications on news.